L'osteodensitometrie dans le depistage de l'osteoporose: le paradoxe Belge

[en] Osteoporosis is considered as a major Public Health issue, in most developed countries. Bone mineral density assessment is the single best predictor of the future fracture risk for an individual. Belgium has the highest number of bone densitometers, per million habitants, in Europe. However, densitometry is not yet reimbursed in Belgium. This situation is rather paradoxical since the demonstration of a prevalent vertebral fracture or of a low bone mineral density is requested to obtain the reimbursement of drugs to be used for the management of osteoporosis. Hopefully, Belgium will soon be online with the requirement s of the European Commission, suggesting to make bone densitometry accessible, through reimbursement.

Disciplines :

Rheumatology

Author, co-author :

NEUPREZ, Audrey ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Gillet, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie appareil locomoteur

Collette, C.

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique

Language :

French

Title :

L'osteodensitometrie dans le depistage de l'osteoporose: le paradoxe Belge

Alternative titles :

[en] Bone Densitometry for the Diagnosis of Osteoporosis: The Belgian Reimbursement Paradox

Publication date :

April 2006

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

Pages :

249-55

Peer reviewed :

Peer reviewed

Available on ORBi :

since 27 August 2009

Statistics

Number of views

269 (8 by ULiège)

Number of downloads

373 (7 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Report Series 843, WHO Publ. Geneva, 1994, 129 pp.
Sembo I, Johnell O.- Consequences of a hip fracture: a prospective study over 1 year. Osteopoross Int, 1993, 3, 148-153.
Meunier PJ. - Prevention of hip fractures. Am J Med, 1993, 95, 75S-78S.
Magaziner J, Lydick E, Hawkes W, et al.- Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Pub Health, 1997, 87, 1630-1636.
Wheren LE, Magaziner J.- Hip fracture: risk factors and outcomes. Curr Osteoporos Rep. 2003, 1, 78-85.
Nydegger V, Rizzoli R, Rapin CH, et al.- Epidemiology of fractures of the proximal femur in Geneva: incidence, clinical and social aspects. Osteoporos Int. 1991, 2, 42-47.
Johnell O, Kanis JA.- An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteopros Int, 2004, 15, 897-902.
Ismail AA, O'Neill TW, Cooper C, et al.- Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int, 1998, 8, 291-297.
Kanis JA, Oden A, Johnell O, et al.- Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int, 2004, 15, 101-112.
Jalava T, Sarna S, Pylkkanen L, et al.- Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res, 2003, 18, 1254-1260.
Adachi JD, Ionnidis G, Pickard L, et al.- The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis study (CaMos). Osteoporos Int, 2003, 14, 895-904.
Melton LJ 3rd, Gabriel SE, Crowson CS, et al.- Cost-equivalence of different osteoporotic fractures. Osteoporos Int, 2003, 14, 383-388.
Gillet P, Reginster JY.- Increased number of hip fractures. Lancet, 1999, 353, 2160-2161.
Autier P, Haentjens P, Bentin J, et al.- Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group. Osteoporos Int, 2000, 11, 373-380.
Reginster JY, Gillet P, Ben Sedrine W, et al.- Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics, 1999, 15, 507-514.
Reginster JY, Gillet P, Gosset C.- Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategy. Bulletin of the World Health Organization, 2001, 79, 942-946.
Boutroy S, Bouxsein ML, Munoz F, et al.- In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab, 2005, 27
Franchimont N.- La qualité osseuse: de la théorie à la réalité. Rev Med Liège, 2005, 60, 707-710.
Brunet-Imbault B, Lemineur G, Chappard C, et al.- A new anisotropy index on trabecular bone radiographic images using the fast Fourier transform. BMC Med Imaging, 2005, 5, 4.
Reginster JY.- Ostéoporose post-ménopausique: traitement prophylactique. Masson Publ. Paris, 1993, 258pp. ISBN 2.225.84221.3
Ben Sedrine W, Reginster JY.- Risk indices and osteoporosis screening: scope and limits. Mayo Clin Proc., 2002, 77, 622-623.
De Laet C, Oden A, Johansson H, et al.- The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int, 2005, 16, 313-318.
Kanis JA, Johnell O, Oden A, et al.- Ten-year risk of osteoporosis fracture and the effect of risk factors on screening strategies. Bone, 2002, 30, 251-258.
Leslie WD, Metge C, Ward L.- Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Osteoporos Int., 2003, 14, 334-348.
Genant HK, Cooper C, Poor G, et al.- Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int., 1999, 10, 259-264.
Johnell O, Kanis JA, Oden A, et al.- Predictive value of BMD for hip and other fractures. J Bone Miner Res., 2005, 20, 1185-1194.
Boonen S, Kaufman JM, Reginster JY, et al.- Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium. Osteoporos Int, 2003, 14, 110-115.
Reginster JY, Devogelaer JP, Kaufman JM, et al.- Comment j'explore...l'ostéoporose: mesure de la masse osseuse et analyses biologiques. Rev Med Liege, 1999, 54, 184-188.
de Laet CE, van der Klift M, Hofman A, et al.- Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res, 2002, 17, 2231-2236.
International Society for Clinical Densitometry.- Updated 2005 Official positions, 2005. www.ISCD.org
Compston J.- Action Plan for the prevention of osteoporotic fractures in the European Community. Osteoporos Int., 2004, 15, 259-262.
European Commission 1998.- Report on osteoporosis in the European Community-action for prevention. 1998 www.osteofound.org/activities/ eu_summary_report.html
US Preventive Services Task force Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med, 2002, 137, 526-528.
Boonen S, Body JJ, Boutsen Y, et al.- Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int, 2005, 16, 239-254.
Kanis JA, Johnell O.- Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int, 2005, 16, 229-238.
International Osteoporosis Foundation. Osteoporosis in Europe: Indicators of progress, 2005. www.osteofound.org/advocacyjiolicy/eu_policy_project.html
Richy F, Ethgen O, Bruyère O, et al.- Primary prevention of osteoporosis: mass screening scenario or prescreening with questionnaires? An economic perspective. J Bone Miner Res, 2004, 19, 1955-1960.
Ben Sedrine W, Broers P, Devogelaer JP, et al.- Interest of a prescreening questionnaire to reduce the cost of bone densitometry. Osteoporos Int, 2002, 13, 434-442.
Ben Sedrine W, Ethgen O, Devogelaer JP, et al.- Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening? Aging Clin Exp Res, 2004, 16, 413-419.